Blog
RSS FeedPosted by Michael Wonder on 03 Nov 2021
Government makes a mockery of PHARMAC review
3 November 2021 - “The ACT Party can today reveal the review into PHARMAC has been delayed by more than ...
Posted by Michael Wonder on 03 Nov 2021
Major PHARMAC review delayed nearly 3 months
3 November 2021 - A major review into Government drug buying agency PHARMAC has been delayed by nearly three months. ...
Posted by Michael Wonder on 31 Oct 2021
New Zealand Pharmaceutical Schedule - November 2021 update
1 November 2021 - The November 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2021
PHARMAC negotiates deal for a further COVID-19 treatment
31 October 2021 - PHARMAC has negotiated an agreement with Roche to purchase another COVID-19 treatment. ...
Posted by Michael Wonder on 20 Oct 2021
PHARMAC says all patients who meet criteria will get next generation diabetes drugs, despite concerns
20 October 2021 - PHARMAC says it will fund next generation diabetes drugs for all people with the condition who ...
Posted by Michael Wonder on 12 Oct 2021
Where is the PHARMAC Review Panel’s interim report?
12 October 2021 - Patient advocacy groups and clinicians are calling out the PHARMAC Review Panel for failing to get their ...
Posted by Michael Wonder on 11 Oct 2021
OIA documents prove PHARMAC's independent inquiry is a toothless whitewash
11 October 2021 - Following a damning survey of PHARMAC, National can also reveal documents received under OIA show the ...
Posted by Michael Wonder on 10 Oct 2021
PHARMAC negotiates deal for molnupiravir to treat COVID-19
11 October 2021 - PHARMAC has negotiated an agreement with supplier MSD to purchase the antiviral molnupiravir. ...
Posted by Michael Wonder on 10 Oct 2021
70 percent of Kiwis want Government to give PHARMAC more money - survey
10 October 2021 - New Zealanders have sent a clear message to the Government to fund medicines better or their ...
Posted by Michael Wonder on 30 Sep 2021
New Zealand Pharmaceutical Schedule - 1 October 2021
1 October 2021 - The October 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 16 Sep 2021
PHARMAC funds tocilizumab to treat cases of COVID-19
16 September 2021 - PHARMAC is widening funded access to tocilizumab, an immunosuppressive drug used mainly to treat arthritis, to treat ...
Posted by Michael Wonder on 16 Sep 2021
PHARMAC funds new treatment for rheumatoid arthritis to support people impacted by tocilizumab stock shortage
16 September 2021 - PHARMAC has funded upadacitinib tablets as an alternative treatment for New Zealanders with severe rheumatoid arthritis, ...
Posted by Michael Wonder on 14 Sep 2021
Limiting the impact on Kiwis as API leaves the NZ market
14 September 2021 - PHARMAC is working hard to limit the impact on over 1 million Kiwis who currently take ...
Posted by Michael Wonder on 06 Sep 2021
New Zealand’s tocilizumab supply to be paused
6 September 2021 - PHARMAC has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New ...
Posted by Michael Wonder on 31 Aug 2021
New Zealand Pharmaceutical Schedule - 1 September 2021 update
1 September 2021 - The September 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...